Currently Viewing:
Newsroom
Currently Reading
What We're Reading: Cutting Public Health Responders; Opioid Payments to Docs; Mistrust of Prescriptions
June 28, 2018 – AJMC Staff
Technology, Data Are No Silver Bullets, but Can Help Turn the Tide of the Opioid Epidemic
June 21, 2018 – Laura Joszt
FDA Approves First Generic Version of Suboxone for Opioid Dependence
June 15, 2018 – Jaime Rosenberg
What We're Reading: CREATES Act Vote; Illegal Opioid Sales; Ebola Funding
June 06, 2018 – AJMC Staff
Opioid Guidelines Putting Pain Management for Patients With Cancer at Risk, Letter Says
May 31, 2018 – Allison Inserro
Studies Evaluate Opioid and Preventive Treatment for Migraine
May 26, 2018 – Alison Rodriguez
Racial Disparities Seen for Black Children Age 5-12 in Youth Suicide
May 21, 2018 – Allison Inserro
AJMC® in the Press, May 18, 2018
May 18, 2018 – AJMC Staff
What We're Reading: Importing Drugs From Canada; House Passes VA Bill; Opioid Withdrawal Treatment
May 17, 2018 – AJMC Staff

What We're Reading: Cutting Public Health Responders; Opioid Payments to Docs; Mistrust of Prescriptions

AJMC Staff
The White House is proposing cutting the Public Health Service Commissioner Corps, which is deployed during disasters and disease outbreaks, by nearly 40%; payments made by opioid manufacturers to physicians have decreased as public attention to the opioid epidemic grows; mistrust of drugs and doctors may partly explain why black patients are less likely than white patients to take recommended statins.

Proposal Would Cut Force That Responds to Public Health Emergencies

The Public Health Service Commissioner Corps currently has 6500 public health professionals who are deployed during disasters and disease outbreaks, but the White House is proposing cutting that force by nearly 40%. The Washington Post reported that the administration wants “a leaner and more efficient organization” made up of no more than 4000 officers. During hurricanes Harvey, Irma, and Maria, more than 1460 officers were sent to respond and nearly 300 went to Liberia during the Ebola epidemic.

 

Opioid Payments to Physicians Decline

Payments made by opioid manufacturers to physicians for speaking, consulting, meals, and travel related to opioids have decreased as public attention to the opioid epidemic grows. In 2016, drug makers paid doctors $15.8 million, which was down from 23.7 million in 2015, according to a report from NPR and ProPublica. Payments for Subsys, a fentanyl spray from Insys, and Hysingla ER, an extended-release version of Purdue Pharma’s hydrocodone, represented the largest drops in spending.

 

Racial Differences in Drug Use a Result of Mistrust

A new study found that mistrust of drugs and doctors may partly explain why black patients are less likely than white patients to take recommended statins. According to Reuters, 82% of black patients said they trusted their physician compared with 94% of white patients. In addition, far fewer black patients thought statins were safe (36% vs 57%) and slightly fewer thought they were effective (70% vs 74%). In general, both groups were receiving doses that were too low: 33% of black patients and 44% of white patients were given doses high enough to comply with guidelines.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up